RTK Group, LLC, ("RTK Group"), an early-stage advisory and investment fund supporting emerging technologies in the biotech and pharmaceutical sector, today announced its participation in seed-round capital funding of Unravel Biosciences, Inc. ("Unravel"). Financial terms of the transaction were not disclosed.